$205.99
5.09[2.53%]
At close: Apr 23
$205.99
0[0.00%]
After Hours: 4:00PM EDT
Steris Stock (NYSE:STE), Analyst Ratings, Price Targets, Predictions
Steris PLC has a consensus price target of $221.5, established from looking at the 38 latest analyst ratings. The last 3 analyst ratings were released from Needham, Stephens & Co., and JMP Securities on April 12, 2024, February 9, 2024, and February 8, 2024. With an average price target of $171.67 between Needham, Stephens & Co., and JMP Securities, there's an implied -16.66% downside for Steris PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Stephens & Co.
JMP Securities
Keybanc
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Steris
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | STE | Buy Now | Steris | $205.99 | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 02/09/2024 | STE | Buy Now | Steris | $205.99 | 21.37% | Stephens & Co. | Jacob Johnson | → $250 | Reiterates | Overweight → Overweight | Get Alert |
| 02/08/2024 | STE | Buy Now | Steris | $205.99 | 28.65% | JMP Securities | David Turkaly | → $265 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/06/2024 | STE | Buy Now | Steris | $205.99 | 22.82% | Keybanc | Brett Fishbin | → $253 | Initiates | → Overweight | Get Alert |
| 12/04/2023 | STE | Buy Now | Steris | $205.99 | 4.37% | Morgan Stanley | Patrick Wood | $225 → $215 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | STE | Buy Now | Steris | $205.99 | 28.65% | JMP Securities | David Turkaly | → $265 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/27/2023 | STE | Buy Now | Steris | $205.99 | 4.37% | Piper Sandler | Jason Bednar | $220 → $215 | Maintains | Neutral | Get Alert |
| 10/26/2023 | STE | Buy Now | Steris | $205.99 | 4.37% | Piper Sandler | Jason Bednar | $220 → $215 | Maintains | Neutral | Get Alert |
| 09/25/2023 | STE | Buy Now | Steris | $205.99 | 21.37% | Stephens & Co. | Jacob Johnson | → $250 | Reiterates | Overweight → Overweight | Get Alert |
| 09/01/2023 | STE | Buy Now | Steris | $205.99 | 28.65% | JMP Securities | David Turkaly | $240 → $265 | Maintains | Market Outperform | Get Alert |
| 08/03/2023 | STE | Buy Now | Steris | $205.99 | 9.23% | Morgan Stanley | Patrick Wood | $206 → $225 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | STE | Buy Now | Steris | $205.99 | 25.25% | Keybanc | Matthew Mishan | $254 → $258 | Maintains | Overweight | Get Alert |
| 08/02/2023 | STE | Buy Now | Steris | $205.99 | 16.51% | JMP Securities | David Turkaly | → $240 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/25/2023 | STE | Buy Now | Steris | $205.99 | 23.31% | Keybanc | Matthew Mishan | $235 → $254 | Maintains | Overweight | Get Alert |
| 07/17/2023 | STE | Buy Now | Steris | $205.99 | 21.37% | Stephens & Co. | Jacob Johnson | $240 → $250 | Maintains | Overweight | Get Alert |
| 05/30/2023 | STE | Buy Now | Steris | $205.99 | — | Morgan Stanley | Patrick Wood | → $206 | Initiates | → Equal-Weight | Get Alert |
| 05/12/2023 | STE | Buy Now | Steris | $205.99 | -2.91% | Piper Sandler | Jason Bednar | $197 → $200 | Maintains | Neutral | Get Alert |
| 05/12/2023 | STE | Buy Now | Steris | $205.99 | 14.08% | Keybanc | Matthew Mishan | $210 → $235 | Maintains | Overweight | Get Alert |
| 05/11/2023 | STE | Buy Now | Steris | $205.99 | 16.51% | JMP Securities | David Turkaly | → $240 | Reiterates | Market Outperform → Market Outperform | Get Alert |
FAQ
What is the target price for Steris (STE)?
The latest price target for Steris (NYSE: STE) was reported by Needham on April 12, 2024. The analyst firm set a price target for $0.00 expecting STE to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Steris (STE)?
The latest analyst rating for Steris (NYSE: STE) was provided by Needham, and Steris reiterated their hold rating.
When was the last upgrade for Steris (STE)?
The last upgrade for Steris PLC happened on May 26, 2021 when Needham raised their price target to $233. Needham previously had a hold for Steris PLC.
When was the last downgrade for Steris (STE)?
The last downgrade for Steris PLC happened on April 14, 2023 when Piper Sandler changed their price target from $215 to $197 for Steris PLC.
When is the next analyst rating going to be posted or updated for Steris (STE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Steris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Steris was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Steris (STE) correct?
While ratings are subjective and will change, the latest Steris (STE) rating was a reiterated with a price target of $0.00 to $0.00. The current price Steris (STE) is trading at is $205.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.